Betalin Therapeutics was selected to participate and compete in Chengdu International Innovation & Entrepreneurship Competition on October 28th and 29th, 2018 at Royal Albert Docks in London, UK. Mr. The competition was hosted by the government of Chengdu in Sichuan province, the leading innovation city in China’s fast developing western region. Shay Herchovici, Betalin’s Head of Business Development, presented Betalin’s innovative solution to cure diabetes, the Engineered Micro Pancreas (EMP). Betalin’s technology and presentation won the 1st Prize that, in addition to the cash award, confers participation in roadshows/training and consultation on market development in China.